Profile data is unavailable for this security.
About the company
Cathay Biotech Inc is a China-based company mainly engaged in the research and development, production and sales of new bio-based materials. The Company's main products include a series of bio-based long-chain dibasic acids (DC10-DC18), bio-based pentamethylenediamine and a series of bio-based polyamides. The Company's brands include Taylon mainly used in the textile field and ECOPENT mainly used in the engineering materials field. The Company's product application areas include civil silk field, industrial silk field, non-woven fabric field, engineering plastics field, and others. The Company is developing bio-based polyamide thermoplastic composite materials, which can be used in new energy equipment, transportation logistics, building decoration and other industries.
- Revenue in CNY (TTM)2.29bn
- Net income in CNY414.34m
- Incorporated2000
- Employees1.80k
- LocationCathay Biotech Inc4th Floor, Building 51690 Cailun Road, China (Shanghai)Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
- Phone+86 2 150801916
- Fax+86 2 150801386
- Websitehttps://www.cathaybiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Skshu Paint Co Ltd | 12.49bn | 194.20m | 19.12bn | 9.83k | 102.27 | 7.67 | -- | 1.53 | 0.3548 | 0.3548 | 23.75 | 4.73 | 0.9308 | 12.78 | 3.16 | 1,270,176.00 | 1.46 | 2.12 | 4.38 | 6.48 | 30.45 | 30.83 | 1.57 | 2.13 | 0.664 | 2.20 | 0.6988 | 36.26 | 10.03 | 28.33 | -47.33 | -4.85 | 16.84 | 3.80 |
| Hubei Xingfa Chemicals Group Co Ltd | 28.42bn | 1.31bn | 20.07bn | 14.59k | 16.35 | 0.9322 | -- | 0.7061 | 1.11 | 1.11 | 24.00 | 19.51 | 0.645 | 11.49 | 16.38 | 1,948,337.00 | 2.95 | 8.10 | 4.06 | 13.69 | 14.51 | 22.93 | 4.58 | 11.72 | 0.5249 | 7.71 | 0.3813 | 21.95 | -7.28 | 9.50 | -76.44 | 31.74 | 20.59 | 24.57 |
| Zhejiang Sanmei Chemical Industry Co Ltd | 3.51bn | 413.96m | 21.12bn | 1.94k | 50.47 | 3.44 | -- | 6.01 | 0.6855 | 0.6855 | 5.82 | 10.06 | 0.5365 | 6.39 | 11.15 | 1,811,749.00 | 6.32 | 7.65 | 6.99 | 8.59 | 16.10 | 19.40 | 11.78 | 11.53 | 5.30 | -- | 0.0286 | 30.13 | -30.12 | -5.63 | -42.41 | -24.07 | 30.25 | -- |
| Jiangsu Yangnong Chemical Co Ltd | 10.15bn | 1.24bn | 22.66bn | 3.50k | 18.16 | 2.22 | -- | 2.23 | 3.07 | 3.07 | 25.09 | 25.13 | 0.628 | 5.82 | 3.45 | 2,900,975.00 | 7.67 | 11.33 | 12.29 | 19.40 | 23.91 | 25.70 | 12.22 | 12.08 | 1.32 | -- | 0.2247 | 19.61 | -27.41 | 5.98 | -12.77 | 9.82 | 15.10 | 5.63 |
| Cathay Biotech Inc | 2.29bn | 414.34m | 23.94bn | 1.80k | 57.66 | 2.13 | -- | 10.44 | 0.7116 | 0.7116 | 3.94 | 19.29 | 0.1246 | 1.15 | 7.28 | 1,271,908.00 | 2.41 | 4.05 | 3.60 | 5.59 | 26.38 | 37.19 | 19.34 | 25.08 | 2.10 | -- | 0.1033 | 30.03 | -13.39 | 3.77 | -33.75 | -4.70 | 30.80 | -- |
| Haohua Chemical Science & Tech Corp Ltd | 7.41bn | 808.98m | 24.15bn | 7.73k | 29.72 | 2.74 | -- | 3.26 | 0.8917 | 0.8917 | 8.19 | 9.68 | 0.485 | 4.94 | 3.40 | 958,529.00 | 5.30 | 7.19 | 7.18 | 9.80 | 26.53 | 26.39 | 10.93 | 12.06 | 1.57 | -- | 0.2673 | 29.77 | -13.40 | 13.05 | -22.76 | 11.21 | 25.48 | 40.59 |
| Zhejiang Longsheng Group Co., Ltd | 15.04bn | 1.39bn | 28.47bn | 5.79k | 19.90 | 0.8338 | -- | 1.89 | 0.4398 | 0.4398 | 4.77 | 10.49 | 0.2095 | 0.3862 | 5.94 | 2,596,915.00 | 2.22 | 6.20 | 3.58 | 9.70 | 25.49 | 34.11 | 10.61 | 20.54 | 1.01 | 10.03 | 0.4426 | 23.48 | -27.90 | -4.31 | -48.92 | -17.90 | -25.13 | 0.00 |
Data as of Jul 22 2024. Currency figures normalised to Cathay Biotech Inc's reporting currency: Chinese Yuan Renminbi CNY
12.28%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| HBM Partners AG (Investment Management)as of 31 Mar 2024 | 35.62m | 6.11% |
| China Asset Management Co., Ltd.as of 30 Sep 2023 | 16.79m | 2.88% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 7.54m | 1.29% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 3.55m | 0.61% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 2023 | 2.64m | 0.45% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 1.93m | 0.33% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 1.39m | 0.24% |
| Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 830.93k | 0.14% |
| JPMorgan Asset Management (China) Co Ltd.as of 31 Dec 2023 | 687.73k | 0.12% |
| Huisheng Fund Management Co., Ltd.as of 31 Dec 2023 | 681.07k | 0.12% |
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.
